{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:58:30Z","timestamp":1783191510666,"version":"3.54.6"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009710","name":"Myocarditis Foundation","doi-asserted-by":"publisher","award":["2018 Rhett Lundy Memorial Research Fellowship"],"award-info":[{"award-number":["2018 Rhett Lundy Memorial Research Fellowship"]}],"id":[{"id":"10.13039\/100009710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["Grover M. Hutchins, M.D. Memorial Research Award"],"award-info":[{"award-number":["Grover M. Hutchins, M.D. Memorial Research Award"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005302","name":"UofI | University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["Illinois Distinguished Fellowships"],"award-info":[{"award-number":["Illinois Distinguished Fellowships"]}],"id":[{"id":"10.13039\/100005302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disease that affects multiple organs simultaneously, complicating diagnosis and treatment. Despite extensive research, tissue-specific autoantigens and precise disease mechanisms remain unclear. Hallmark SLE autoantibodies primarily target nuclear antigens ubiquitously expressed across all tissues, limiting their diagnostic and therapeutic specificity. Myocarditis is a severe cardiovascular complication of SLE with a high mortality. However, not all patients with lupus myocarditis test positive for hallmark SLE antibodies, and their titers show no significant differences between patients with SLE with and without myocarditis, suggesting the involvement of additional, unidentified mechanisms. Autoimmunity against cardiac myosin heavy chain (MyHC) is a well-established driver of various forms of autoimmune myocarditis. However, the role of autoreactive T cells and autoantibodies targeting MyHC or other cardiac antigens in lupus myocarditis remains largely unknown. Here, in this Review, we offer an overview of the current knowledge on autoreactive T cells and autoantibodies identified in primary SLE or autoimmune myocarditis conditions from both clinical and preclinical studies. We also propose a novel two-stage model for lupus myocarditis pathogenesis, integrating both nuclear and cardiac antigen targets. Finally, we discuss antigen-specific regulatory T cells and chimeric antigen receptor T cells as promising therapeutic strategies for future research and clinical applications.<\/jats:p>","DOI":"10.1038\/s12276-025-01580-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:27:02Z","timestamp":1762493222000},"page":"2408-2417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathogenic drivers of lupus myocarditis and potential therapeutic targets"],"prefix":"10.1038","volume":"57","author":[{"given":"Yushan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Fan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-2016","authenticated-orcid":false,"given":"Taejoon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann. Rheum. Dis. 82, 351\u2013356 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1580_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","volume":"35","author":"E Gomez-Banuelos","year":"2023","unstructured":"Gomez-Banuelos, E., Fava, A. & Andrade, F. An update on autoantibodies in systemic lupus erythematosus. Curr. Opin. Rheumatol. 35, 61\u201367 (2023).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1580_CR3","first-page":"1265","volume":"22","author":"M Abu-Shakra","year":"1995","unstructured":"Abu-Shakra, M. et al. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J. Rheumatol. 22, 1265\u20131270 (1995).","journal-title":"J. Rheumatol."},{"key":"1580_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10741-020-10054-w","volume":"26","author":"M Guglin","year":"2021","unstructured":"Guglin, M., Smith, C. & Rao, R. The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock. Heart Fail. Rev. 26, 553\u2013560 (2021).","journal-title":"Heart Fail. Rev."},{"key":"1580_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/rheumatology\/keac409","volume":"62","author":"R du Toit","year":"2023","unstructured":"du Toit, R. et al. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology 62, 523\u2013534 (2023).","journal-title":"Rheumatology"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","volume":"16","author":"DS Pisetsky","year":"2020","unstructured":"Pisetsky, D. S. & Lipsky, P. E. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 16, 565\u2013579 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1580_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/antib5010002","volume":"5","author":"B Dema","year":"2016","unstructured":"Dema, B. & Charles, N. Autoantibodies in SLE: specificities, isotypes and receptors. Antibodies 5, 2 (2016).","journal-title":"Antibodies"},{"key":"1580_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0961203319897116","volume":"29","author":"Y Gartshteyn","year":"2020","unstructured":"Gartshteyn, Y. et al. Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus. Lupus 29, 199\u2013204 (2020).","journal-title":"Lupus"},{"key":"1580_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4078\/jrd.2021.28.3.165","volume":"28","author":"SY Lee","year":"2021","unstructured":"Lee, S. Y. et al. Fatal myopericarditis in a patient with lupus erythematosus supported by extracorporeal membrane oxygenation: a case report. J. Rheum. Dis. 28, 165\u2013170 (2021).","journal-title":"J. Rheum. Dis."},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.kint.2020.05.051","volume":"99","author":"D Abdirama","year":"2021","unstructured":"Abdirama, D. et al. Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys. Kidney Int. 99, 238\u2013246 (2021). p.","journal-title":"Kidney Int."},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/ard.61.9.779","volume":"61","author":"G Riemekasten","year":"2002","unstructured":"Riemekasten, G. et al. T cell reactivity against the SmD1(83\u2013119) C terminal peptide in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 61, 779\u2013785 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1073\/pnas.1424796112","volume":"112","author":"NH Kattah","year":"2015","unstructured":"Kattah, N. H. et al. Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. Proc. Natl Acad. Sci. USA 112, 3044\u20133049 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1580_CR13","first-page":"575","volume":"18","author":"A Psarras","year":"2022","unstructured":"Psarras, A., Wittmann, M. & Vital, E. M. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat. Rev. Rheumatol. 18, 575\u2013590 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"102979","DOI":"10.1016\/j.jaut.2022.102979","volume":"137","author":"SL Coss","year":"2023","unstructured":"Coss, S. L. et al. The complement system and human autoimmune diseases. J. Autoimmun. 137, 102979 (2023).","journal-title":"J. Autoimmun."},{"key":"1580_CR15","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1172\/JCI44583","volume":"121","author":"H Lv","year":"2011","unstructured":"Lv, H. et al. Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J. Clin. Invest 121, 1561\u20131573 (2011).","journal-title":"J. Clin. Invest"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/hrt.74.6.598","volume":"74","author":"JH Goldman","year":"1995","unstructured":"Goldman, J. H. et al. Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br. Heart J. 74, 598\u2013603 (1995).","journal-title":"Br. Heart J."},{"key":"1580_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-022-05432-3","volume":"611","author":"ML Axelrod","year":"2022","unstructured":"Axelrod, M. L. et al. T cells specific for alpha-myosin drive immunotherapy-related myocarditis. Nature 611, 818\u2013826 (2022). p.","journal-title":"Nature"},{"key":"1580_CR18","doi-asserted-by":"publisher","first-page":"111611","DOI":"10.1016\/j.celrep.2022.111611","volume":"41","author":"T Won","year":"2022","unstructured":"Won, T. et al. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis. Cell Rep. 41, 111611 (2022).","journal-title":"Cell Rep."},{"key":"1580_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/CIRCRESAHA.124.323816","volume":"134","author":"T Won","year":"2024","unstructured":"Won, T. et al. Autoimmune myocarditis, old dogs and new tricks. Circ. Res 134, 1767\u20131790 (2024).","journal-title":"Circ. Res"},{"key":"1580_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","volume":"18","author":"VA Ryabkova","year":"2019","unstructured":"Ryabkova, V. A. et al. Lethal immunoglobulins: autoantibodies and sudden cardiac death. Autoimmun. Rev. 18, 415\u2013425 (2019).","journal-title":"Autoimmun. Rev."},{"key":"1580_CR21","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.4049\/jimmunol.181.4.2513","volume":"181","author":"JA Lucas","year":"2008","unstructured":"Lucas, J. A. et al. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J. Immunol. 181, 2513\u20132521 (2008).","journal-title":"J. Immunol."},{"key":"1580_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/intimm\/dxq026","volume":"22","author":"J Wang","year":"2010","unstructured":"Wang, J. et al. PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol. 22, 443\u2013452 (2010).","journal-title":"Int Immunol."},{"key":"1580_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2011.11.018","volume":"36","author":"A Gall","year":"2012","unstructured":"Gall, A. et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120\u2013131 (2012).","journal-title":"Immunity"},{"key":"1580_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1242\/dmm.027409","volume":"10","author":"MG Hasham","year":"2017","unstructured":"Hasham, M. G. et al. Systemic autoimmunity induced by the TLR7\/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease. Dis. Model Mech. 10, 259\u2013270 (2017).","journal-title":"Dis. Model Mech."},{"key":"1580_CR25","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio, A. L. P. et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur. Heart J. 38, 2649\u20132662 (2017).","journal-title":"Eur. Heart J."},{"key":"1580_CR26","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","volume":"23","author":"PM Seferovic","year":"2021","unstructured":"Seferovic, P. M. et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur. J. Heart Fail. 23, 854\u2013871 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"1580_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/rheumatology\/kep102","volume":"48","author":"GJ Pons-Estel","year":"2009","unstructured":"Pons-Estel, G. J. et al. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. Rheumatology 48, 817\u2013822 (2009).","journal-title":"Rheumatology"},{"key":"1580_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","volume":"43","author":"SR Schoenfeld","year":"2013","unstructured":"Schoenfeld, S. R., Kasturi, S. & Costenbader, K. H. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum. 43, 77\u201395 (2013).","journal-title":"Semin Arthritis Rheum."},{"key":"1580_CR29","doi-asserted-by":"publisher","first-page":"e190010","DOI":"10.1148\/ryct.2019190010","volume":"1","author":"JA Luetkens","year":"2019","unstructured":"Luetkens, J. A. et al. Comparison of Original and 2018 Lake Louise Criteria for Diagnosis of Acute Myocarditis: results of a validation cohort. Radio. Cardiothorac. Imaging 1, e190010 (2019).","journal-title":"Radio. Cardiothorac. Imaging"},{"key":"1580_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1148\/radiol.2019192094","volume":"294","author":"MS Davenport","year":"2020","unstructured":"Davenport, M. S. et al. Use of Intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 294, 660\u2013668 (2020).","journal-title":"Radiology"},{"key":"1580_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2967\/jnmt.115.165639","volume":"44","author":"J Alchammas","year":"2016","unstructured":"Alchammas, J. et al. The evaluation of lupus myocarditis with 13N-ammonia and 18F-FDG PET. J. Nucl. Med Technol. 44, 210\u2013211 (2016).","journal-title":"J. Nucl. Med Technol."},{"key":"1580_CR32","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1177\/0961203320936748","volume":"29","author":"R du Toit","year":"2020","unstructured":"du Toit, R. et al. Myocardial injury in systemic lupus erythematosus according to cardiac magnetic resonance tissue characterization: clinical and echocardiographic features. Lupus 29, 1461\u20131468 (2020).","journal-title":"Lupus"},{"key":"1580_CR33","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich, M. G. et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J. Am. Coll. Cardiol. 53, 1475\u20131487 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1580_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/ard.49.8.627","volume":"49","author":"D Logar","year":"1990","unstructured":"Logar, D. et al. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann. Rheum. Dis. 49, 627\u2013629 (1990).","journal-title":"Ann. Rheum. Dis."},{"key":"1580_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.160493","volume":"44","author":"G Thomas","year":"2017","unstructured":"Thomas, G. et al. Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J. Rheumatol. 44, 24\u201332 (2017).","journal-title":"J. Rheumatol."},{"key":"1580_CR36","doi-asserted-by":"publisher","unstructured":"Ramirez, G. A. et al. Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study. Rheumatology (Oxford). 64, 1904\u22121911 https:\/\/doi.org\/10.1093\/rheumatology\/keae376 (2025).","DOI":"10.1093\/rheumatology\/keae376"},{"key":"1580_CR37","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1177\/0961203312456752","volume":"21","author":"GM Zawadowski","year":"2012","unstructured":"Zawadowski, G. M. et al. A contemporary case series of lupus myocarditis. Lupus 21, 1378\u20131384 (2012).","journal-title":"Lupus"},{"key":"1580_CR38","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/keaa540","volume":"60","author":"R du Toit","year":"2021","unstructured":"du Toit, R. et al. Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus. Rheumatology 60, 2010\u20132021 (2021).","journal-title":"Rheumatology"},{"key":"1580_CR39","doi-asserted-by":"publisher","first-page":"117626","DOI":"10.1016\/j.atherosclerosis.2024.117626","volume":"396","author":"N Ben-Shabat","year":"2024","unstructured":"Ben-Shabat, N. et al. Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: results from a large population-based study. Atherosclerosis 396, 117626 (2024).","journal-title":"Atherosclerosis"},{"key":"1580_CR40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/acr.20540","volume":"63","author":"PE Lazzerini","year":"2011","unstructured":"Lazzerini, P. E. et al. Anti-Ro\/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity. Arthritis Care Res. 63, 1463\u20131470 (2011).","journal-title":"Arthritis Care Res."},{"key":"1580_CR41","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","volume":"103","author":"GQ Xiao","year":"2001","unstructured":"Xiao, G. Q., Hu, K. & Boutjdir, M. Direct inhibition of expressed cardiac L- and T-type calcium channels by igg from mothers whose children have congenital heart block. Circulation 103, 1599\u20131604 (2001).","journal-title":"Circulation"},{"key":"1580_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.1780330502","volume":"33","author":"JP Buyon","year":"1990","unstructured":"Buyon, J. P. & Winchester, R. Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum. 33, 609\u2013614 (1990).","journal-title":"Arthritis Rheum."},{"key":"1580_CR43","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/art.22860","volume":"56","author":"ML Eloranta","year":"2007","unstructured":"Eloranta, M. L. et al. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies. Arthritis Rheum. 56, 3112\u20133124 (2007).","journal-title":"Arthritis Rheum."},{"key":"1580_CR44","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.4049\/jimmunol.165.9.5345","volume":"165","author":"ME Miranda-Carus","year":"2000","unstructured":"Miranda-Carus, M. E. et al. Anti-SSA\/Ro and anti-SSB\/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J. Immunol. 165, 5345\u20135351 (2000).","journal-title":"J. Immunol."},{"key":"1580_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yexcr.2014.01.003","volume":"325","author":"A Ambrosi","year":"2014","unstructured":"Ambrosi, A., Sonesson, S. E. & Wahren-Herlenius, M. Molecular mechanisms of congenital heart block. Exp. Cell Res. 325, 2\u20139 (2014).","journal-title":"Exp. Cell Res."},{"key":"1580_CR46","doi-asserted-by":"publisher","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","volume":"380","author":"JS Knight","year":"2023","unstructured":"Knight, J. S., Branch, D. W. & Ortel, T. L. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ 380, e069717 (2023).","journal-title":"BMJ"},{"key":"1580_CR47","doi-asserted-by":"publisher","first-page":"914468","DOI":"10.3389\/fimmu.2022.914468","volume":"13","author":"AS Elshikha","year":"2022","unstructured":"Elshikha, A. S. et al. TLR7 activation accelerates cardiovascular pathology in a mouse model of lupus. Front Immunol. 13, 914468 (2022).","journal-title":"Front Immunol."},{"key":"1580_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10554-023-02970-3","volume":"40","author":"KA Myhr","year":"2024","unstructured":"Myhr, K. A. et al. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus. Int. J. Cardiovasc. Imaging 40, 127\u2013137 (2024).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"1580_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","volume":"82","author":"P Nihoyannopoulos","year":"1990","unstructured":"Nihoyannopoulos, P. et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 82, 369\u2013375 (1990).","journal-title":"Circulation"},{"key":"1580_CR50","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/rheumatology\/keac596","volume":"62","author":"N Farina","year":"2023","unstructured":"Farina, N. et al. Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events. Rheumatology 62, 2252\u20132256 (2023).","journal-title":"Rheumatology"},{"key":"1580_CR51","doi-asserted-by":"publisher","first-page":"101503","DOI":"10.1016\/j.cpcardiol.2022.101503","volume":"48","author":"V Nevras","year":"2023","unstructured":"Nevras, V. et al. Acute coronary syndromes in antiphospholipid syndrome-above suspicion: a systematic review. Curr. Probl. Cardiol. 48, 101503 (2023).","journal-title":"Curr. Probl. Cardiol."},{"key":"1580_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-2007-984406","volume":"24","author":"M Marnach","year":"2007","unstructured":"Marnach, M., VanWinter, J. & Watson, W. Myocarditis: an unusual cause of postpartum fever in pregnancy complicated by antiphospholipid syndrome. Am. J. Perinatol. 24, 405\u2013408 (2007).","journal-title":"Am. J. Perinatol."},{"key":"1580_CR53","doi-asserted-by":"publisher","first-page":"ytac446","DOI":"10.1093\/ehjcr\/ytac446","volume":"6","author":"AC Lai","year":"2022","unstructured":"Lai, A. C. et al. A case report of acute heart failure and cardiogenic shock caused by catastrophic antiphospholipid syndrome and lupus myocarditis. Eur. Heart J. Case Rep. 6, ytac446 (2022).","journal-title":"Eur. Heart J. Case Rep."},{"key":"1580_CR54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/eurheartj\/12.suppl_D.88","volume":"12","author":"IK De Scheerder","year":"1991","unstructured":"De Scheerder, I. K. et al. Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur. Heart J. 12, 88\u201394 (1991).","journal-title":"Eur. Heart J."},{"key":"1580_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0735-1097(10)80331-6","volume":"16","author":"DA Neumann","year":"1990","unstructured":"Neumann, D. A. et al. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J. Am. Coll. Cardiol. 16, 839\u2013846 (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1580_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0735-1097(99)00485-4","volume":"35","author":"B Lauer","year":"2000","unstructured":"Lauer, B. et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J. Am. Coll. Cardiol. 35, 11\u201318 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1580_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12016-010-8229-8","volume":"44","author":"U Nussinovitch","year":"2013","unstructured":"Nussinovitch, U. & Shoenfeld, Y. The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin. Rev. Allergy Immunol. 44, 98\u2013108 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"1580_CR58","first-page":"1284","volume":"15","author":"RE Wolf","year":"1988","unstructured":"Wolf, R. E., King, J. W. & Brown, T. A. Antimyosin antibodies and constrictive pericarditis in lupus erythematosus. J. Rheumatol. 15, 1284\u20131287 (1988).","journal-title":"J. Rheumatol."},{"key":"1580_CR59","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s44161-024-00525-w","volume":"3","author":"S Fleischer","year":"2024","unstructured":"Fleischer, S. et al. An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Nat. Cardiovasc. Res. 3, 1123\u20131139 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1580_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Suarez-Fueyo","year":"2016","unstructured":"Suarez-Fueyo, A., Bradley, S. J. & Tsokos, G. C. T cells in systemic lupus erythematosus. Curr. Opin. Immunol. 43, 32\u201338 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"1580_CR61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi, A. & Tsokos, G. C. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat. Rev. Rheumatol. 16, 100\u2013112 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1580_CR62","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","volume":"9","author":"A Perl","year":"2013","unstructured":"Perl, A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 9, 674\u2013686 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1580_CR63","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B","volume":"44","author":"EJ Enyedy","year":"2001","unstructured":"Enyedy, E. J. et al. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 44, 1114\u20131121 (2001).","journal-title":"Arthritis Rheum."},{"key":"1580_CR64","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/art.1780331109","volume":"33","author":"B Richardson","year":"1990","unstructured":"Richardson, B. et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33, 1665\u20131673 (1990).","journal-title":"Arthritis Rheum."},{"key":"1580_CR65","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.4049\/jimmunol.172.12.7821","volume":"172","author":"S Krishnan","year":"2004","unstructured":"Krishnan, S. et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172, 7821\u20137831 (2004).","journal-title":"J. Immunol."},{"key":"1580_CR66","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","volume":"182","author":"DR Fernandez","year":"2009","unstructured":"Fernandez, D. R. et al. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation. J. Immunol. 182, 2063\u20132073 (2009).","journal-title":"J. Immunol."},{"key":"1580_CR67","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga, T. et al. Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus. Arthritis Rheumatol. 71, 766\u2013772 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1580_CR68","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/intimm\/13.9.1155","volume":"13","author":"F Monneaux","year":"2001","unstructured":"Monneaux, F. et al. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL\/Fas(lpr) and (NZB x NZW)F(1) lupus mice. Int. Immunol. 13, 1155\u20131163 (2001).","journal-title":"Int. Immunol."},{"key":"1580_CR69","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1084\/jem.183.6.2459","volume":"183","author":"A Kaliyaperumal","year":"1996","unstructured":"Kaliyaperumal, A. et al. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183, 2459\u20132469 (1996).","journal-title":"J. Exp. Med."},{"key":"1580_CR70","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1084\/jem.184.5.1857","volume":"184","author":"P Reynolds","year":"1996","unstructured":"Reynolds, P. et al. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J. Exp. Med. 184, 1857\u20131870 (1996).","journal-title":"J. Exp. Med."},{"key":"1580_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78223-3","volume":"10","author":"S Tesch","year":"2020","unstructured":"Tesch, S. et al. Identification and characterization of antigen-specific CD4+ T cells targeting renally expressed antigens in human lupus nephritis with two independent methods. Sci. Rep. 10, 21312 (2020).","journal-title":"Sci. Rep."},{"key":"1580_CR72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","volume":"30","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson, R. et al. Mixed connective tissue disease. Best. Pr. Res Clin. Rheumatol. 30, 95\u2013111 (2016).","journal-title":"Best. Pr. Res Clin. Rheumatol."},{"key":"1580_CR73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1191\/0961203306lu2283rr","volume":"15","author":"PJ Venables","year":"2006","unstructured":"Venables, P. J. Mixed connective tissue disease. Lupus 15, 132\u2013137 (2006).","journal-title":"Lupus"},{"key":"1580_CR74","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0896-8411(05)80041-1","volume":"3","author":"RM O\u2019Brien","year":"1990","unstructured":"O\u2019Brien, R. M. et al. T-cell epitopes on the 70-kDa protein of the (U1)RNP complex in autoimmune rheumatologic disorders. J. Autoimmun. 3, 747\u2013757 (1990).","journal-title":"J. Autoimmun."},{"key":"1580_CR75","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaccas.2019.05.032","volume":"1","author":"S Figliozzi","year":"2019","unstructured":"Figliozzi, S. et al. Biopsy-proven lymphocytic myocarditis with heart failure in a middle-aged female patient with mixed connective tissue disease. JACC Case Rep. 1, 171\u2013174 (2019).","journal-title":"JACC Case Rep."},{"key":"1580_CR76","doi-asserted-by":"publisher","first-page":"ytad174","DOI":"10.1093\/ehjcr\/ytad174","volume":"7","author":"T Hamana","year":"2023","unstructured":"Hamana, T. et al. Fulminant myocarditis in a young woman with mixed connective tissue disease: a case report. Eur. Heart J. Case Rep. 7, ytad174 (2023).","journal-title":"Eur. Heart J. Case Rep."},{"key":"1580_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85851","volume":"1","author":"JM Myers","year":"2016","unstructured":"Myers, J. M. et al. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight 1, e85851 (2016).","journal-title":"JCI Insight"},{"key":"1580_CR78","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1172\/JCI118642","volume":"97","author":"CL Pummerer","year":"1996","unstructured":"Pummerer, C. L. et al. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB\/c mice. J. Clin. Invest 97, 2057\u20132062 (1996).","journal-title":"J. Clin. Invest"},{"key":"1580_CR79","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.182.5.1291","volume":"182","author":"DL Donermeyer","year":"1995","unstructured":"Donermeyer, D. L. et al. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J. Exp. Med. 182, 1291\u20131300 (1995).","journal-title":"J. Exp. Med."},{"key":"1580_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0090-1229(90)90039-S","volume":"57","author":"M Kodama","year":"1990","unstructured":"Kodama, M. et al. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57, 250\u2013262 (1990).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"1580_CR81","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","volume":"41","author":"JM Schenkel","year":"2014","unstructured":"Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886\u2013897 (2014).","journal-title":"Immunity"},{"key":"1580_CR82","doi-asserted-by":"publisher","first-page":"eabl6157","DOI":"10.1126\/scitranslmed.abl6157","volume":"14","author":"D Frieser","year":"2022","unstructured":"Frieser, D. et al. Tissue-resident CD8+ T cells drive compartmentalized and chronic autoimmune damage against CNS neurons. Sci. Transl. Med. 14, eabl6157 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1580_CR83","doi-asserted-by":"publisher","first-page":"112514","DOI":"10.1016\/j.celrep.2023.112514","volume":"42","author":"GAM Povoleri","year":"2023","unstructured":"Povoleri, G. A. M. et al. Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets. Cell Rep. 42, 112514 (2023).","journal-title":"Cell Rep."},{"key":"1580_CR84","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/ecco-jcc\/jjz010","volume":"13","author":"S Bishu","year":"2019","unstructured":"Bishu, S. et al. CD4+ tissue-resident memory t cells expand and are a major source of mucosal tumour necrosis factor alpha in active Crohn\u2019s disease. J. Crohns Colitis 13, 905\u2013915 (2019).","journal-title":"J. Crohns Colitis"},{"key":"1580_CR85","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/09612033211017218","volume":"30","author":"HJ Gu","year":"2021","unstructured":"Gu, H. J. et al. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus. Lupus 30, 1427\u20131437 (2021).","journal-title":"Lupus"},{"key":"1580_CR86","doi-asserted-by":"publisher","first-page":"102424","DOI":"10.1016\/j.jaut.2020.102424","volume":"109","author":"M Zhou","year":"2020","unstructured":"Zhou, M. et al. JAK\/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis. J. Autoimmun. 109, 102424 (2020).","journal-title":"J. Autoimmun."},{"key":"1580_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05951-9","volume":"22","author":"Y Lai","year":"2024","unstructured":"Lai, Y. et al. Novel approach to alleviate lupus nephritis: targeting the NLRP3 inflammasome in CD8+CD69+CD103+ T(RM) cells. J. Transl. Med. 22, 1139 (2024).","journal-title":"J. Transl. Med."},{"key":"1580_CR88","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1172\/JCI120859","volume":"128","author":"JS Tilstra","year":"2018","unstructured":"Tilstra, J. S. et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J. Clin. Invest. 128, 4884\u20134897 (2018).","journal-title":"J. Clin. Invest."},{"key":"1580_CR89","doi-asserted-by":"publisher","first-page":"e2323052121","DOI":"10.1073\/pnas.2323052121","volume":"121","author":"H Kalinoski","year":"2024","unstructured":"Kalinoski, H. et al. Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis. Proc. Natl Acad. Sci. USA 121, e2323052121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1580_CR90","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/138920207783591690","volume":"8","author":"SC Gough","year":"2007","unstructured":"Gough, S. C. & Simmonds, M. J. The HLA region and autoimmune disease: associations and mechanisms of action. Curr. Genom. 8, 453\u2013465 (2007).","journal-title":"Curr. Genom."},{"key":"1580_CR91","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/ard.62.10.1017","volume":"62","author":"E Endreffy","year":"2003","unstructured":"Endreffy, E. et al. HLA class II allele polymorphism in Hungarian patients with systemic lupus erythematosus. Ann. Rheum. Dis. 62, 1017\u20131018 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"1580_CR92","doi-asserted-by":"publisher","first-page":"e000554","DOI":"10.1136\/lupus-2021-000554","volume":"9","author":"M Selvaraja","year":"2022","unstructured":"Selvaraja, M. et al. Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different?. Lupus Sci. Med. 9, e000554 (2022).","journal-title":"Lupus Sci. Med."},{"key":"1580_CR93","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.humimm.2004.09.008","volume":"65","author":"LM Cortes","year":"2004","unstructured":"Cortes, L. M. et al. HLA class II haplotypes in Mexican systemic lupus erythematosus patients. Hum. Immunol. 65, 1469\u20131476 (2004).","journal-title":"Hum. Immunol."},{"key":"1580_CR94","doi-asserted-by":"publisher","first-page":"13447","DOI":"10.1073\/pnas.2235552100","volume":"100","author":"JF Elliott","year":"2003","unstructured":"Elliott, J. F. et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc. Natl Acad. Sci. USA 100, 13447\u201313452 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1580_CR95","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.4049\/jimmunol.172.4.2651","volume":"172","author":"JA Taylor","year":"2004","unstructured":"Taylor, J. A. et al. A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J. Immunol. 172, 2651\u20132658 (2004).","journal-title":"J. Immunol."},{"key":"1580_CR96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1071-9164(97)90041-5","volume":"3","author":"MD Lozano","year":"1997","unstructured":"Lozano, M. D. et al. Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis Treatment Trial Investigators. J. Card. Fail. 3, 97\u2013103 (1997).","journal-title":"J. Card. Fail."},{"key":"1580_CR97","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI115158","volume":"87","author":"FC Arnett","year":"1991","unstructured":"Arnett, F. C. et al. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J. Clin. Invest. 87, 1490\u20131495 (1991).","journal-title":"J. Clin. Invest."},{"key":"1580_CR98","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1016\/j.cell.2024.08.025","volume":"187","author":"S Mori","year":"2024","unstructured":"Mori, S. et al. Neoself-antigens are the primary target for autoreactive T cells in human lupus. Cell 187, 6071\u20136087 e20 (2024).","journal-title":"Cell"},{"key":"1580_CR99","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0092-8674(00)81025-9","volume":"84","author":"P Cresswell","year":"1996","unstructured":"Cresswell, P. Invariant chain structure and MHC class II function. Cell 84, 505\u2013507 (1996).","journal-title":"Cell"},{"key":"1580_CR100","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0140-6736(11)60648-X","volume":"379","author":"S Sagar","year":"2012","unstructured":"Sagar, S., Liu, P. P. & Cooper, L. T. Jr. Myocarditis. Lancet 379, 738\u2013747 (2012).","journal-title":"Lancet"},{"key":"1580_CR101","doi-asserted-by":"publisher","unstructured":"Vitzthum von Eckstaedt, H. et al. Immune checkpoint inhibitors and lupus erythematosus. Pharmaceuticals 17, 252 https:\/\/doi.org\/10.3390\/ph17020252 (2024)","DOI":"10.3390\/ph17020252"},{"key":"1580_CR102","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/0961203319878493","volume":"28","author":"SM Abo El-Khair","year":"2019","unstructured":"Abo El-Khair, S. M. et al. Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females. Lupus 28, 1427\u20131434 (2019).","journal-title":"Lupus"},{"key":"1580_CR103","doi-asserted-by":"publisher","first-page":"36885","DOI":"10.18632\/oncotarget.16378","volume":"8","author":"J Gao","year":"2017","unstructured":"Gao, J. et al. Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk. Oncotarget 8, 36885\u201336897 (2017).","journal-title":"Oncotarget"},{"key":"1580_CR104","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl, A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat. Rev. Rheumatol. 12, 169\u2013182 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1580_CR105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2015.00038","volume":"6","author":"RT Sowell","year":"2015","unstructured":"Sowell, R. T. & Marzo, A. L. Resident-memory CD8 T cells and mTOR: generation, protection, and clinical importance. Front Immunol. 6, 38 (2015).","journal-title":"Front Immunol."},{"key":"1580_CR106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","volume":"110","author":"LS Chan","year":"1998","unstructured":"Chan, L. S. et al. Epitope spreading: lessons from autoimmune skin diseases. J. Invest. Dermatol. 110, 103\u2013109 (1998).","journal-title":"J. Invest. Dermatol."},{"key":"1580_CR107","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clim.2005.07.002","volume":"117","author":"US Deshmukh","year":"2005","unstructured":"Deshmukh, U. S. et al. Epitope spreading within lupus-associated ribonucleoprotein antigens. Clin. Immunol. 117, 112\u2013120 (2005).","journal-title":"Clin. Immunol."},{"key":"1580_CR108","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1580_CR109","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1365-2567.2005.02306.x","volume":"117","author":"JH Lee","year":"2006","unstructured":"Lee, J. H. et al. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117, 280\u2013286 (2006).","journal-title":"Immunology"},{"key":"1580_CR110","doi-asserted-by":"publisher","unstructured":"Huang, J. et al. Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis. Front. Immunol. 15, 1425847 https:\/\/doi.org\/10.3389\/fimmu.2024.1425847 (2024)","DOI":"10.3389\/fimmu.2024.1425847"},{"key":"1580_CR111","doi-asserted-by":"publisher","unstructured":"Yu, J. et al. Inflammatory factor-mediated miR-155\/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. Int. Immunopharmacol. 141, 113013 https:\/\/doi.org\/10.1016\/j.intimp.2024.113013 (2024)","DOI":"10.1016\/j.intimp.2024.113013"},{"key":"1580_CR112","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan, J., Jin, H. & Xu, Y. T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus. Front Immunol. 11, 1027 (2020).","journal-title":"Front Immunol."},{"key":"1580_CR113","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/art.40380","volume":"70","author":"H Kato","year":"2017","unstructured":"Kato, H. & Perl, A. Blockade of Treg cell differentiation and function by the interleukin-21\u2013mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus. Arthritis Rheumatol. 70, 427\u2013738 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1580_CR114","doi-asserted-by":"publisher","unstructured":"Martins, S. et al. Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy. BMC Cardiovas. Disord. 23, 89 https:\/\/doi.org\/10.1186\/s12872-023-03109-x (2023).","DOI":"10.1186\/s12872-023-03109-x"},{"key":"1580_CR115","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/imm.12728","volume":"151","author":"Y Wei","year":"2017","unstructured":"Wei, Y. et al. CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy. Immunology 151, 291\u2013303 (2017).","journal-title":"Immunology"},{"key":"1580_CR116","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00109-016-1414-3","volume":"94","author":"L Yan","year":"2016","unstructured":"Yan, L. et al. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17\/Treg immune response. J. Mol. Med. 94, 1063\u20131079 (2016).","journal-title":"J. Mol. Med."},{"key":"1580_CR117","doi-asserted-by":"publisher","first-page":"103865","DOI":"10.1016\/j.isci.2022.103865","volume":"25","author":"N Lasrado","year":"2022","unstructured":"Lasrado, N. et al. Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing. iScience 25, 103865 (2022).","journal-title":"iScience"},{"key":"1580_CR118","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.4049\/jimmunol.176.8.4748","volume":"176","author":"M Ono","year":"2006","unstructured":"Ono, M. et al. Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25\u2212 regulatory T cells. J. Immunol. 176, 4748\u20134756 (2006).","journal-title":"J. Immunol."},{"key":"1580_CR119","doi-asserted-by":"publisher","unstructured":"Thonhoff, J. et al. Expanded autologous regulatory T-lymphocyte infusions in ALS. Neurology 5, e465 https:\/\/doi.org\/10.1212\/NXI.0000000000000465 (2018)","DOI":"10.1212\/NXI.0000000000000465"},{"key":"1580_CR120","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/gutjnl-2022-327075","volume":"72","author":"C Voskens","year":"2023","unstructured":"Voskens, C. et al. Autologous regulatory T-\u00adcell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis. Gut 72, 49\u201353 (2023).","journal-title":"Gut"},{"key":"1580_CR121","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.4049\/jimmunol.177.3.1451","volume":"177","author":"KJ Scalapino","year":"2006","unstructured":"Scalapino, K. J. et al. Suppression of disease in New Zealand Black\/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177, 1451\u20131459 (2006).","journal-title":"J. Immunol."},{"key":"1580_CR122","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1073\/pnas.0903158107","volume":"107","author":"JY Humrich","year":"2010","unstructured":"Humrich, J. Y. et al. Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl Acad. Sci. USA 107, 204\u2013209 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1580_CR123","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.119.045344","volume":"142","author":"C Cui","year":"2020","unstructured":"Cui, C. et al. CD4+ T-cell endogenous cystathionine gamma lyase-hydrogen sulfide attenuates hypertension by sulfhydrating liver kinase B1 to promote T regulatory cell differentiation and proliferation. Circulation 142, 1752\u20131769 (2020).","journal-title":"Circulation"},{"key":"1580_CR124","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/cvr\/cvp182","volume":"84","author":"J Feng","year":"2009","unstructured":"Feng, J. et al. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE\u2212\/\u2212 mice. Cardiovasc. Res. 84, 155\u2013163 (2009).","journal-title":"Cardiovasc. Res."},{"key":"1580_CR125","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","volume":"121","author":"Y Shi","year":"2010","unstructured":"Shi, Y. et al. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Circulation 121, 2624\u20132634 (2010).","journal-title":"Circulation"},{"key":"1580_CR126","doi-asserted-by":"publisher","first-page":"1166135","DOI":"10.3389\/fimmu.2023.1166135","volume":"14","author":"JA Bluestone","year":"2023","unstructured":"Bluestone, J. A. et al. Opportunities for Treg cell therapy for the treatment of human disease. Front. Immunol. 14, 1166135 (2023).","journal-title":"Front. Immunol."},{"key":"1580_CR127","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","volume":"143","author":"P Desreumaux","year":"2012","unstructured":"Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn\u2019s disease. Gastroenterology 143, 1207\u20131217 (2012).","journal-title":"Gastroenterology"},{"key":"1580_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45056-x","volume":"15","author":"PJ Eggenhuizen","year":"2024","unstructured":"Eggenhuizen, P. J. et al. Smith-specific regulatory T cells halt the progression of lupus nephritis. Nat. Commun. 15, 899 (2024).","journal-title":"Nat. Commun."},{"key":"1580_CR129","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RM Larson","year":"2021","unstructured":"Larson, R. M. M., Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145\u2013161 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1580_CR130","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nrclinonc.2016.36","volume":"13","author":"HJ Jackson","year":"2016","unstructured":"Jackson, H. J., Rafiq, S. & Brentjens, R. J. Driving CAR T-cells forward. Nat. Rev. Clin. Oncol. 13, 370\u2013383 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1580_CR131","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/s41423-020-0472-1","volume":"18","author":"X Jin","year":"2021","unstructured":"Jin, X. et al. Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus. Cell Mol. Immunol. 18, 1896\u20131903 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"1580_CR132","doi-asserted-by":"publisher","unstructured":"Kansal, R. et al. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus. Sci. Transl. Med. 11, eaav1648 https:\/\/doi.org\/10.1126\/scitranslmed.aav1648 (2019)","DOI":"10.1126\/scitranslmed.aav1648"},{"key":"1580_CR133","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124\u20132132 (2022).","journal-title":"Nat. Med."},{"key":"1580_CR134","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F Muller","year":"2024","unstructured":"Muller, F. et al. CD19 CAR T-cell therapy in autoimmune disease\u2014a case series with follow-up. N. Engl. J. Med. 390, 687\u2013700 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1580_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03262-w","volume":"21","author":"J Frikeche","year":"2024","unstructured":"Frikeche, J. et al. MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis. J. Neuroinflammation 21, 268 (2024).","journal-title":"J. Neuroinflammation"},{"key":"1580_CR136","doi-asserted-by":"crossref","unstructured":"Doglio, M. et al. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in systemic lupus erythematosus. Nat. Commun. 15, 2542 (2024)","DOI":"10.1038\/s41467-024-46448-9"},{"key":"1580_CR137","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","volume":"27","author":"ME Allen","year":"2021","unstructured":"Allen, M. E., Rus, V. & Szeto, G. L. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol. Med. 27, 152\u2013171 (2021).","journal-title":"Trends Mol. Med."},{"key":"1580_CR138","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","volume":"29","author":"D Chaussabel","year":"2008","unstructured":"Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150\u2013164 (2008).","journal-title":"Immunity"},{"key":"1580_CR139","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der, E. et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat. Immunol. 20, 915\u2013927 (2019).","journal-title":"Nat. Immunol."},{"key":"1580_CR140","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565 (2016).","journal-title":"Cell"},{"key":"1580_CR141","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1177\/0961203320948959","volume":"29","author":"NA Young","year":"2020","unstructured":"Young, N. A. et al. Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis. Lupus 29, 1790\u20131799 (2020).","journal-title":"Lupus"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:03:07Z","timestamp":1765296187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":141,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01580-4","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}